We are live on ! Find out more
2L

22NW LP Portfolio holdings

AUM $146M
1-Year Est. Return 29.83%
This Fund
S&P 500
This Quarter Est. Return
-7.9%
1 Year Est. Return
+29.83%
3 Year Est. Return
+131.37%
5 Year Est. Return
+199.25%
10 Year Est. Return
–
AUM
$177M
AUM Growth
-$11.6M
Cap. Flow
+$19.9M
Cap. Flow %
11.27%
Top 10 Hldgs %
72.68%
Holding
20
New
–
Increased
6
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ANEB
Anebulo Pharmaceuticals
ANEB
+$6.05M
2
LFCR icon
Lifecore Biomedical
LFCR
+$4.2M
3
MED icon
Medifast
MED
+$3.4M
4
FARM
Farmer Brothers
FARM
+$2.78M
5
CULP icon
Culp Inc
CULP
+$2.28M

Top Sells

Rank Stock Value
1
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$50.2K

Sector Composition

Rank Sector Weight
1 Industrials 23.49%
2 Healthcare 21.31%
3 Technology 17.32%
4 Materials 16.82%
5 Consumer Discretionary 13.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OEC icon
1
Orion
OEC
$394M
$18.4M 10.41%
1,378,452
– –
AGYS icon
2
Agilysys
AGYS
$2.78B
$15.7M 8.86%
283,125
– –
LFCR icon
3
Lifecore Biomedical
LFCR
$162M
$15.6M 8.82%
1,755,161
+412,945
+31% +$4.2M
ANEB
4
DELISTED
Anebulo Pharmaceuticals
ANEB
$14.2M 8.02%
5,066,290
+1,703,577
+51% +$6.05M
BBSI icon
5
Barrett Business Services
BBSI
$976M
$13.9M 7.86%
712,692
– –
STRL icon
6
Sterling Infrastructure
STRL
$20.3B
$12.9M 7.3%
601,201
– –
FSTR icon
7
Foster
FSTR
$443M
$9.99M 5.65%
1,023,135
– –
MED icon
8
Medifast
MED
$108M
$9.71M 5.49%
89,596
+23,700
+36% +$3.4M
FARM
9
DELISTED
Farmer Brothers
FARM
$9.17M 5.19%
1,955,526
+538,227
+38% +$2.78M
MCFT icon
10
MasterCraft Boat Holdings
MCFT
$588M
$8.97M 5.07%
475,797
– –
MFGP
11
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$7.96M 4.5%
1,396,928
– –
DRTT
12
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
$6.99M 3.95%
15,894,165
– –
GPRE icon
13
Green Plains
GPRE
$1.19B
$5.96M 3.37%
205,196
– –
NTIC icon
14
Northern Technologies International Corp
NTIC
$76.4M
$5.37M 3.04%
403,215
– –
CULP icon
15
Culp Inc
CULP
$45M
$5.29M 2.99%
1,212,380
+481,475
+66% +$2.28M
MTW icon
16
Manitowoc
MTW
$516M
$4.74M 2.68%
611,058
– –
MACK
17
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.62M 2.61%
1,231,014
-10,882
-0.9% -$50.2K
PFX icon
18
PhenixFIN
PFX
$83.9M
$4.11M 2.33%
117,885
– –
SSKN
19
DELISTED
Strata Skin Sciences
SSKN
$3M 1.69%
343,926
+125,275
+57% +$1.27M
LIAN
20
DELISTED
LianBio American Depositary Shares
LIAN
$282K 0.16%
141,223
– –

Similar funds

TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
AFM
Aspetuck Financial Management Westport, Connecticut $146M AUM 33.29% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
AWM
Apex Wealth Management Bedford, New Hampshire $146M AUM 15.52% 1-Year Est. Return
AGP
Aspire Growth Partners Miromar Lakes, Florida $146M AUM 22.8% 1-Year Est. Return
SIM
Sentry Investment Management Stevens Point, Wisconsin $146M AUM 23.67% 1-Year Est. Return
AC
Anson Capital Tyrone, Georgia $146M AUM 18.69% 1-Year Est. Return
ECM
Endure Capital Management Austin, Texas $146M AUM

22NW LP's Q3 2022 Portfolio in Review

As of Q3 2022, 22NW LP held 20 positions worth $177M, down 6.2% from $188M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

22NW LP deployed $19.9M of net new capital in Q3 2022, adding to 6 existing holdings.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merrimack Pharmaceuticals, Inc., an estimated $50.2K trimmed.

  • 22NW LP added most to Anebulo Pharmaceuticals in Q3 2022, an estimated $6.05M increase.
  • 22NW LP's biggest Q3 2022 reduction was Merrimack Pharmaceuticals, Inc., cutting an estimated $50.2K.
  • 22NW LP's ten largest holdings make up 73% of its $177M portfolio in Q3 2022.
  • 22NW LP opened 0 new positions and closed 0 in Q3 2022.
  • 22NW LP's portfolio value fell 6.2% quarter-over-quarter to $177M.

Based on 22NW LP's 13F filing for Q3 2022, filed 14 Nov 2022.